Lakeland, FL -- (SBWIRE) -- 02/21/2013 -- Penny Stock Divas is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our best penny stock picks.
Radient Pharmaceuticals Corp (PINK:RXPC) during previous trading session the stock showed a negative movement of -66.67%.
Graph values of the stockdemonstrate these trends:1 Year performance of the stock remained negative with the decline of -99.83%. The RXPC traded with volume of 178.63 million shares, while its average trading ability remained 59.03 million shares.
What RXPC’s Charts Are Signaling for Traders? Find Out Here
Currently company is having a market capitalization of $134,794. Stock’s closing price was $0.0001 while it started its day-trade at $0.0003; its 52-week price range was $0.0001 - $0.066.Radient Pharmaceuticals Corporation engages in the research, development, manufacture, sale, and marketing of medical diagnostic products. It offers Onko-Sure, a proprietary in-vitro diagnostic cancer test, which is used for the detection and/or monitoring of the presence of colon, rectal, lung, stomach, tongue, ovarian, uterine, liver, pancreatic, bladder, brain, esophageal, hematological, breast, prostate, cervical, thyroid, lymphoma, and trophoblast cancers.
MAXAM GOLD CORP (PINK:MXAM) stock’s trade opened at $0.0004 and as day trade closed its price was $0.0002 after decreasing-60% .The market capitalization of MXAM was 35,000. Total traded volume of the stock was 175.07 million shares while company’s average volume remained 24.66 million shares.
Should MXAM a Buy or Sell Now? Find Out Here
MXAM’s day range remained $0.0002 - $0.0005 while its 52 week range was $0.0002 - $0.0067. During last 5 trades the stock plummeted almost -66.67%. During last 3 month it slipped with the percentage of -91.3. Its year to date performance remained adverse with -60%.Maxam Gold Corporation engages in the acquisition, exploration, mining, and milling of gold, and other precious and non-precious metals. Its principal property, Peoria Seven mine, which is located south of Gila Bend, Arizona, holds 640 acres of the company’s claims. Maxam was founded by Dale L. Runyon in 1974.
TRANZBYTE CORPORATIO (PINK:ERBB) remained among the day losers and traded with volume of 147.63 million shares in the last session as compared to average volume of 77.49 million shares.
Previous 5 days graph demonstrated an adverse move of -42.36%. ERBB’s quarterly performance remained green with the percentage of 38.33, while its year to date performance showed that the stock advanced overall 232%.
Can ERBB Show a Strong Recovery? Find out in This Research Report
52 week range of the stock remained $0.0008 - $0.0193, while its day lowest price was $0.0071 and its hit its day highest price at $0.0101. ERBB’s total market capitalization is $6.43 million. Tranzbyte Corporation, through its subsidiaries, operates independently owned retail dispensaries under the Altitude Organic Medicine brand name in Colorado, California, and Arizona. It also offers specialized business support services; and sells horticulture equipment. In addition, the company produces and sells a portfolio of RFID readers, tags, desktop starter kits, sensor tags, sensor probes, desktop and mobile readers, embedded readers, and RFID-enabled data logging tags.
About Penny Stock Divas
PSD is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our penny stock picks. We use social media tools such as Twitter and Facebook, enabling you to receive time sensitive information in a real-time manner. When you sign up for our FREE penny stock newsletter, you will receive our latest hot penny stock alerts! We have new investment ideas for penny stocks with research and commentary in the penny stock market.
PSD is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and the company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)